US Stock MarketDetailed Quotes

Barinthus Biotherapeutics (BRNS)

Watchlist
  • 0.6420
  • +0.0030+0.47%
Close Apr 24 16:00 ET
26.22MMarket Cap-0.39P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Barinthus Biotherapeutics (BRNS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-65.79%-47.98M
-132.42%-4.24M
41.06%-10.73M
-50.83%-18.11M
-26.05%-14.9M
43.17%-28.94M
166.76%13.09M
-62.61%-18.2M
29.20%-12.01M
-272.46%-11.82M
Net income from continuing operations
-8.62%-66.46M
46.08%-11.1M
-79.25%-14.57M
-24.69%-21.13M
-26.66%-19.66M
16.70%-61.18M
-19.09%-20.59M
42.39%-8.13M
28.88%-16.94M
14.83%-15.52M
Operating gains losses
638.83%3.5M
106.10%163K
-148.14%-1.25M
577.43%3M
254.68%1.59M
-108.62%-649K
-140.15%-2.67M
141.73%2.61M
-87.76%443K
-129.28%-1.03M
Depreciation and amortization
0.78%5.85M
-36.34%909K
-38.92%901K
36.40%2M
42.24%2.03M
6.83%5.8M
-0.49%1.43M
0.07%1.48M
12.93%1.47M
17.12%1.43M
Deferred tax
-297.73%-175K
-2,000.00%-57K
-2,266.67%-71K
-257.14%-25K
40.54%-22K
98.57%-44K
100.37%3K
99.50%-3K
99.38%-7K
92.83%-37K
Other non cash items
44.63%3.41M
-62.04%585K
73,850.00%1.48M
35.51%519K
91.65%826K
67.04%2.36M
198.07%1.54M
108.33%2K
-30.87%383K
18.41%431K
Change In working capital
-113.80%-359K
-77.31%3.44M
90.44%-1.46M
-250.96%-2.2M
-110.66%-137K
-57.85%2.6M
239.24%15.15M
-285.20%-15.29M
168.63%1.46M
-84.43%1.29M
-Change in receivables
373.65%6.42M
-73.00%3.47M
99.07%-145K
-269.25%-1.16M
1,383.08%4.25M
-141.34%-2.35M
2,424.95%12.86M
-1,510.14%-15.55M
429.46%683K
-104.69%-331K
-Change in prepaid assets
-53.23%1.7M
-18.08%1.28M
-47.45%957K
64.10%-579K
-97.44%48K
65.59%3.64M
151.16%1.56M
-14.99%1.82M
-64.09%-1.61M
-54.16%1.88M
-Change in payables and accrued expense
-542.76%-6M
-152.56%-801K
29.12%-1.61M
-97.19%97K
-172.98%-3.68M
197.76%1.35M
121.66%1.52M
-131.23%-2.28M
150.11%3.45M
55.43%-1.35M
-Change in other current assets
----
----
----
----
----
--0
--0
--0
--0
--0
-Change in other current liabilities
-10.62%-1.98M
-3.93%-502K
-3.49%-504K
-4.65%-495K
-38.15%-478K
-302.02%-1.79M
-8.54%-483K
---487K
---473K
---346K
-Change in other working capital
-129.11%-506K
97.39%-8K
-112.95%-156K
89.08%-65K
-119.32%-277K
--1.74M
---306K
--1.21M
---595K
--1.43M
Cash from discontinued investing activities
Operating cash flow
-65.79%-47.98M
-132.42%-4.24M
41.06%-10.73M
-50.83%-18.11M
-26.05%-14.9M
43.17%-28.94M
166.76%13.09M
-62.61%-18.2M
29.20%-12.01M
-272.46%-11.82M
Investing cash flow
Cash flow from continuing investing activities
146.64%416K
100.72%2K
495.61%451K
83.33%-32K
98.38%-5K
83.52%-892K
-281.70%-278K
-216.67%-114K
93.65%-192K
87.71%-308K
Net PPE purchase and sale
146.64%416K
100.72%2K
495.61%451K
83.33%-32K
98.38%-5K
83.52%-892K
-281.70%-278K
-216.67%-114K
93.65%-192K
87.71%-308K
Cash from discontinued investing activities
Investing cash flow
146.64%416K
100.72%2K
495.61%451K
83.33%-32K
98.38%-5K
83.52%-892K
-281.70%-278K
-216.67%-114K
93.65%-192K
87.71%-308K
Financing cash flow
Cash flow from continuing financing activities
-99.91%2K
0
0
0
-99.60%2K
15.54%2.16M
667.89%837K
910.87%465K
1,178.57%358K
-70.22%503K
Net common stock issuance
--0
--0
--0
--0
--0
6.29%2.16M
667.89%837K
910.87%465K
293.41%358K
-71.88%503K
Proceeds from stock option exercised by employees
--2K
--0
--0
--0
--2K
--0
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
-99.91%2K
--0
--0
--0
-99.60%2K
15.54%2.16M
667.89%837K
910.87%465K
1,178.57%358K
-70.22%503K
Net cash flow
Beginning cash position
-20.90%112.4M
-28.68%75.67M
-25.46%87.78M
-22.61%100.58M
-20.90%112.4M
-26.90%142.09M
-33.81%106.1M
-31.93%117.77M
-32.07%129.97M
-26.90%142.09M
Current changes in cash
-71.89%-47.56M
-131.07%-4.24M
42.43%-10.28M
-53.22%-18.14M
-28.19%-14.91M
49.20%-27.67M
170.55%13.65M
-59.62%-17.85M
40.66%-11.84M
-191.26%-11.63M
Effect of exchange rate changes
447.01%7.01M
105.69%418K
-129.72%-1.84M
1,597.48%5.35M
726.83%3.08M
-193.09%-2.02M
-754.81%-7.35M
500.97%6.18M
-121.58%-357K
-152.62%-492K
End cash Position
-36.07%71.85M
-36.07%71.85M
-28.68%75.67M
-25.46%87.78M
-22.61%100.58M
-20.90%112.4M
-20.90%112.4M
-33.81%106.1M
-31.93%117.77M
-32.07%129.97M
Free cash flow
-60.95%-48.02M
-133.12%-4.24M
41.43%-10.73M
-48.72%-18.14M
-22.89%-14.91M
47.05%-29.83M
165.85%12.81M
-63.11%-18.31M
38.95%-12.2M
-113.52%-12.13M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -65.79%-47.98M-132.42%-4.24M41.06%-10.73M-50.83%-18.11M-26.05%-14.9M43.17%-28.94M166.76%13.09M-62.61%-18.2M29.20%-12.01M-272.46%-11.82M
Net income from continuing operations -8.62%-66.46M46.08%-11.1M-79.25%-14.57M-24.69%-21.13M-26.66%-19.66M16.70%-61.18M-19.09%-20.59M42.39%-8.13M28.88%-16.94M14.83%-15.52M
Operating gains losses 638.83%3.5M106.10%163K-148.14%-1.25M577.43%3M254.68%1.59M-108.62%-649K-140.15%-2.67M141.73%2.61M-87.76%443K-129.28%-1.03M
Depreciation and amortization 0.78%5.85M-36.34%909K-38.92%901K36.40%2M42.24%2.03M6.83%5.8M-0.49%1.43M0.07%1.48M12.93%1.47M17.12%1.43M
Deferred tax -297.73%-175K-2,000.00%-57K-2,266.67%-71K-257.14%-25K40.54%-22K98.57%-44K100.37%3K99.50%-3K99.38%-7K92.83%-37K
Other non cash items 44.63%3.41M-62.04%585K73,850.00%1.48M35.51%519K91.65%826K67.04%2.36M198.07%1.54M108.33%2K-30.87%383K18.41%431K
Change In working capital -113.80%-359K-77.31%3.44M90.44%-1.46M-250.96%-2.2M-110.66%-137K-57.85%2.6M239.24%15.15M-285.20%-15.29M168.63%1.46M-84.43%1.29M
-Change in receivables 373.65%6.42M-73.00%3.47M99.07%-145K-269.25%-1.16M1,383.08%4.25M-141.34%-2.35M2,424.95%12.86M-1,510.14%-15.55M429.46%683K-104.69%-331K
-Change in prepaid assets -53.23%1.7M-18.08%1.28M-47.45%957K64.10%-579K-97.44%48K65.59%3.64M151.16%1.56M-14.99%1.82M-64.09%-1.61M-54.16%1.88M
-Change in payables and accrued expense -542.76%-6M-152.56%-801K29.12%-1.61M-97.19%97K-172.98%-3.68M197.76%1.35M121.66%1.52M-131.23%-2.28M150.11%3.45M55.43%-1.35M
-Change in other current assets ----------------------0--0--0--0--0
-Change in other current liabilities -10.62%-1.98M-3.93%-502K-3.49%-504K-4.65%-495K-38.15%-478K-302.02%-1.79M-8.54%-483K---487K---473K---346K
-Change in other working capital -129.11%-506K97.39%-8K-112.95%-156K89.08%-65K-119.32%-277K--1.74M---306K--1.21M---595K--1.43M
Cash from discontinued investing activities
Operating cash flow -65.79%-47.98M-132.42%-4.24M41.06%-10.73M-50.83%-18.11M-26.05%-14.9M43.17%-28.94M166.76%13.09M-62.61%-18.2M29.20%-12.01M-272.46%-11.82M
Investing cash flow
Cash flow from continuing investing activities 146.64%416K100.72%2K495.61%451K83.33%-32K98.38%-5K83.52%-892K-281.70%-278K-216.67%-114K93.65%-192K87.71%-308K
Net PPE purchase and sale 146.64%416K100.72%2K495.61%451K83.33%-32K98.38%-5K83.52%-892K-281.70%-278K-216.67%-114K93.65%-192K87.71%-308K
Cash from discontinued investing activities
Investing cash flow 146.64%416K100.72%2K495.61%451K83.33%-32K98.38%-5K83.52%-892K-281.70%-278K-216.67%-114K93.65%-192K87.71%-308K
Financing cash flow
Cash flow from continuing financing activities -99.91%2K000-99.60%2K15.54%2.16M667.89%837K910.87%465K1,178.57%358K-70.22%503K
Net common stock issuance --0--0--0--0--06.29%2.16M667.89%837K910.87%465K293.41%358K-71.88%503K
Proceeds from stock option exercised by employees --2K--0--0--0--2K--0--0--0--0--0
Cash from discontinued financing activities
Financing cash flow -99.91%2K--0--0--0-99.60%2K15.54%2.16M667.89%837K910.87%465K1,178.57%358K-70.22%503K
Net cash flow
Beginning cash position -20.90%112.4M-28.68%75.67M-25.46%87.78M-22.61%100.58M-20.90%112.4M-26.90%142.09M-33.81%106.1M-31.93%117.77M-32.07%129.97M-26.90%142.09M
Current changes in cash -71.89%-47.56M-131.07%-4.24M42.43%-10.28M-53.22%-18.14M-28.19%-14.91M49.20%-27.67M170.55%13.65M-59.62%-17.85M40.66%-11.84M-191.26%-11.63M
Effect of exchange rate changes 447.01%7.01M105.69%418K-129.72%-1.84M1,597.48%5.35M726.83%3.08M-193.09%-2.02M-754.81%-7.35M500.97%6.18M-121.58%-357K-152.62%-492K
End cash Position -36.07%71.85M-36.07%71.85M-28.68%75.67M-25.46%87.78M-22.61%100.58M-20.90%112.4M-20.90%112.4M-33.81%106.1M-31.93%117.77M-32.07%129.97M
Free cash flow -60.95%-48.02M-133.12%-4.24M41.43%-10.73M-48.72%-18.14M-22.89%-14.91M47.05%-29.83M165.85%12.81M-63.11%-18.31M38.95%-12.2M-113.52%-12.13M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -